[ad_1]
summary
Rose Capeding, former director of the dengue department of the Tropical Medicine Research Institute of Manila, has been indicted in a series of criminal cases for failing to introduce in the Philippines of Dengvaxia, a dengue vaccine withdrawn from the market in 2017 due to safety concerns. In February, a panel of prosecutors concluded that there was a probable cause to indict Capeding and 19 others for "reckless recklessness resulting from [in] Homicide, "because of their role in the approval and deployment of the vaccine.If she is found guilty of charges against her by the Department of Justice, Capeding could incur up to 48 years in prison. Many scientists have defended it.
Source link
